BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 35570599)

  • 1. Clinically Different Presentations of Family Members With the Same Homozygote Diacylglycerol Kinase Epsilon Mutation: Case Report.
    Çelikkaya E; Güngör T; Karakaya D; Kargın Çakıcı E; Yazılıtaş F; Özaltın F; Bülbül M
    Exp Clin Transplant; 2022 May; 20(Suppl 3):45-48. PubMed ID: 35570599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Phenotypic Spectrum of Nephropathies Associated with Mutations in Diacylglycerol Kinase
    Azukaitis K; Simkova E; Majid MA; Galiano M; Benz K; Amann K; Bockmeyer C; Gajjar R; Meyers KE; Cheong HI; Lange-Sperandio B; Jungraithmayr T; Frémeaux-Bacchi V; Bergmann C; Bereczki C; Miklaszewska M; Csuka D; Prohászka Z; Killen P; Gipson P; Sampson MG; Lemaire M; Schaefer F
    J Am Soc Nephrol; 2017 Oct; 28(10):3066-3075. PubMed ID: 28526779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement mutations in diacylglycerol kinase-ε-associated atypical hemolytic uremic syndrome.
    Sánchez Chinchilla D; Pinto S; Hoppe B; Adragna M; Lopez L; Justa Roldan ML; Peña A; Lopez Trascasa M; Sánchez-Corral P; Rodríguez de Córdoba S
    Clin J Am Soc Nephrol; 2014 Sep; 9(9):1611-9. PubMed ID: 25135762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel compound heterozygous mutation of the
    Lau SHY; Chan EYH; Yuen LYP; Ng WF; Ma ALT
    Hong Kong Med J; 2023 Aug; 29(4):351-354. PubMed ID: 37433757
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term outcomes and response to treatment in diacylglycerol kinase epsilon nephropathy.
    Brocklebank V; Kumar G; Howie AJ; Chandar J; Milford DV; Craze J; Evans J; Finlay E; Freundlich M; Gale DP; Inward C; Mraz M; Jones C; Wong W; Marks SD; Connolly J; Corner BM; Smith-Jackson K; Walsh PR; Marchbank KJ; Harris CL; Wilson V; Wong EKS; Malina M; Johnson S; Sheerin NS; Kavanagh D
    Kidney Int; 2020 Jun; 97(6):1260-1274. PubMed ID: 32386968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rare genetic variant in the CFB gene presenting as atypical hemolytic uremic syndrome and immune complex diffuse membranoproliferative glomerulonephritis, with crescents, successfully treated with eculizumab.
    Alfakeeh K; Azar M; Alfadhel M; Abdullah AM; Aloudah N; Alsaad KO
    Pediatr Nephrol; 2017 May; 32(5):885-891. PubMed ID: 28210841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a New DGKE Intronic Mutation in Genetically Unsolved Cases of Familial Atypical Hemolytic Uremic Syndrome.
    Mele C; Lemaire M; Iatropoulos P; Piras R; Bresin E; Bettoni S; Bick D; Helbling D; Veith R; Valoti E; Donadelli R; Murer L; Neunhäuserer M; Breno M; Frémeaux-Bacchi V; Lifton R; Remuzzi G; Noris M
    Clin J Am Soc Nephrol; 2015 Jun; 10(6):1011-9. PubMed ID: 25854283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membrano-proliferative glomerulonephritis, atypical hemolytic uremic syndrome, and a new complement factor H mutation: report of a case.
    Gnappi E; Allinovi M; Vaglio A; Bresin E; Sorosina A; Pilato FP; Allegri L; Manenti L
    Pediatr Nephrol; 2012 Oct; 27(10):1995-9. PubMed ID: 22669321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical features and outcomes of patients with diacylglycerol kinase epsilon nephropathy: a nationwide experience.
    Khandelwal P; Thangaraju S; Krishnamurthy S; Ohri A; Pais P; Mathew G; Sharma J; Sharma A; Hari P; Sinha A; Singh G; Bagga A
    Pediatr Nephrol; 2023 Sep; 38(9):3009-3016. PubMed ID: 36988693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary membranoproliferative glomerulonephritis due to hemolytic uremic syndrome: an unusual presentation.
    Jha V; Murthy MS; Kohli HS; Sud K; Gupta KL; Joshi K; Sakhuja V
    Ren Fail; 1998 Nov; 20(6):845-50. PubMed ID: 9834983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of primary nephrotic syndrome in elderly Japanese: retrospective analysis of the Japan Renal Biopsy Registry (J-RBR).
    Yokoyama H; Sugiyama H; Narita I; Saito T; Yamagata K; Nishio S; Fujimoto S; Mori N; Yuzawa Y; Okuda S; Maruyama S; Sato H; Ueda Y; Makino H; Matsuo S
    Clin Exp Nephrol; 2015 Jun; 19(3):496-505. PubMed ID: 25230687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DGKE variants cause a glomerular microangiopathy that mimics membranoproliferative GN.
    Ozaltin F; Li B; Rauhauser A; An SW; Soylemezoglu O; Gonul II; Taskiran EZ; Ibsirlioglu T; Korkmaz E; Bilginer Y; Duzova A; Ozen S; Topaloglu R; Besbas N; Ashraf S; Du Y; Liang C; Chen P; Lu D; Vadnagara K; Arbuckle S; Lewis D; Wakeland B; Quigg RJ; Ransom RF; Wakeland EK; Topham MK; Bazan NG; Mohan C; Hildebrandt F; Bakkaloglu A; Huang CL; Attanasio M
    J Am Soc Nephrol; 2013 Feb; 24(3):377-84. PubMed ID: 23274426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical features of children with anti-CFH autoantibody-associated hemolytic uremic syndrome: a report of 8 cases.
    Li Q; Kong X; Tian M; Wang J; Yang Z; Yu L; Liu S; Wang C; Wang X; Sun S
    Ren Fail; 2022 Dec; 44(1):1061-1069. PubMed ID: 35730179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Familial membranoproliferative glomerulonephritis].
    Bogdanović RM; Dimitrjević JZ; Nikolić VN; Ognjanović MV; Rodić BD; Slavković BV
    Srp Arh Celok Lek; 1999; 127(5-6):163-71. PubMed ID: 10500423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Various phenotypes of disease associated with mutated DGKE gene.
    Bezdíčka M; Pavlíček P; Bláhová K; Háček J; Zieg J
    Eur J Med Genet; 2020 Aug; 63(8):103953. PubMed ID: 32413569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spectrum of steroid-resistant and congenital nephrotic syndrome in children: the PodoNet registry cohort.
    Trautmann A; Bodria M; Ozaltin F; Gheisari A; Melk A; Azocar M; Anarat A; Caliskan S; Emma F; Gellermann J; Oh J; Baskin E; Ksiazek J; Remuzzi G; Erdogan O; Akman S; Dusek J; Davitaia T; Özkaya O; Papachristou F; Firszt-Adamczyk A; Urasinski T; Testa S; Krmar RT; Hyla-Klekot L; Pasini A; Özcakar ZB; Sallay P; Cakar N; Galanti M; Terzic J; Aoun B; Caldas Afonso A; Szymanik-Grzelak H; Lipska BS; Schnaidt S; Schaefer F;
    Clin J Am Soc Nephrol; 2015 Apr; 10(4):592-600. PubMed ID: 25635037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole exome sequencing revealed a novel homozygous variant in the DGKE catalytic domain: a case report of familial hemolytic uremic syndrome.
    Gholizad-Kolveiri S; Hooman N; Alizadeh R; Hoseini R; Otukesh H; Talebi S; Akouchekian M
    BMC Med Genet; 2020 Aug; 21(1):169. PubMed ID: 32838746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postpartum thrombotic microangiopathy revealed as atypical hemolytic uremic syndrome successfully treated with eculizumab: a case report.
    Kourouklaris A; Ioannou K; Athanasiou I; Panagidou A; Demetriou K; Zavros M
    J Med Case Rep; 2014 Sep; 8():307. PubMed ID: 25219386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical Hemolytic Uremic Syndrome Associated with Complement Factor H Mutation and IgA Nephropathy: A Case Report Successfully Treated with Eculizumab.
    Nakamura H; Anayama M; Makino M; Makino Y; Tamura K; Nagasawa M
    Nephron; 2018; 138(4):324-327. PubMed ID: 29241200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment aspects of primary nephrotic syndrome in adults.
    Rasić S; Uncanin S; Dzemidzić J; Aganović K; Srna A; Rasić I
    Bosn J Basic Med Sci; 2006 May; 6(2):16-20. PubMed ID: 16879107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.